Search Results  for '002294.SZ'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Shenzhen Salubris Pharmaceuticals Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

18 Apr 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - SHENZHEN SALUBRIS PHARMACEUTICALS CO LTD (002294-SZ)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

17 Apr 2015 Thomson Reuters Stock Report 11 $25.00

华融证券_公司研究_医药行业_信立泰(002294)年报点评:低估值有望填平,稳增长寻求突破_推荐_张科然_20150326

26 Mar 2015 Huarong Securities Co., Ltd 5 $10.00

Company Snapshot - Shenzhen Salubris Pharma Co Ltd

A director at Shenzhen Salubris Pharma Co Ltd sold 11,706 shares at 44.290CNY and the significance rating of the trade was 68...

25 Mar 2015 Directors Deals Ltd. 1 $12.00

Wright Investors Service Comprehensive Report for Shenzhen Salubris Pharmaceuticals Co Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

07 Mar 2015 Wright Reports 55 $75.00

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) - Financial Analysis Review

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) - Financial Analysis Review Summary Shenzhen Salubris Pharmaceutic...

12 Feb 2015 GlobalData 24 $125.00

Will Shenzhen Salubris Pharmaceuticals Co Ltd Deliver Long-Term Returns?

04 Feb 2015 Sadif Analytics Prime 12 $25.00

华融证券_公司研究_医药行业_信立泰(002294):年报业绩快报符合预期_推荐_张科然_20150121

22 Jan 2015 Huarong Securities Co., Ltd 5 $10.00

Will Shenzhen Salubris Pharmaceuticals Co Ltd Deliver Long-Term Returns?

11 Nov 2014 Sadif Analytics Prime 12 $25.00

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) - Financial Analysis Review

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) - Financial Analysis Review Summary Shenzhen Salubris Pharmaceutic...

07 Oct 2014 GlobalData 24 $125.00